Gabriel, Rodney A.
Seng, Eri C.
Curran, Brian P.
Winston, Paul
Trescot, Andrea M.
Filipovski, Igor
Article History
Accepted: 6 June 2024
First Online: 4 July 2024
Declarations
:
: Dr. Gabriel’s institution received funding for research from Epimed, Teleflex, Merck, Takeda, and SPR Therapeutics. Dr. Gabriel’s institution serves as a consultant for Avanos, which Dr. Gabriel represents. Dr. Trescot has served on an advisory board for Atricure, (Mason, OH) and is the Chief Medical Officer for Stimwave Technologies (Pompano, FL). Paul Winston has received educational grants and honoraria from AbbVie, Ipsen, Merz, and Pacira Biosciences.
: Dr. Gabriel’s institution received funding for research from Epimed, Teleflex, Merck, Takeda, and SPR Therapeutics. Dr. Gabriel’s institution serves as a consultant for Avanos, which Dr. Gabriel represents. Dr. Trescot has served on an advisory board for Atricure, (Mason, OH) and is the Chief Medical Officer for Stimwave Technologies (Pompano, FL). Paul Winston has received educational grants and honoraria from AbbVie, Ipsen, Merz, and Pacira Biosciences.